<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><description>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 26 Jan 2021 20:42:37 +0800</pubDate><image><url>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</url><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>新冠疫苗动态：默沙东终止疫苗研发，Moderna 疫苗对新冠突变株有效</title><link>https://mp.weixin.qq.com/s/qdWwHuQ7Ski6B4XXXS3pVQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYhsMIxib1xkhagpkX2FZjbO4ln6KwaSDg7oiagAuXnndv0r1e6f3BkRiaOAGNE8tbQ5FOibtQthBzxmA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Tue, 26 Jan 2021 17:53:11 +0800</pubDate></item><item><title>头对头伊布替尼！阿斯利康 BTK 抑制剂阿卡替尼 III 期临床达主要终点</title><link>https://mp.weixin.qq.com/s/EJg5plJVmE9FAhWDdcohug</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYhsMIxib1xkhagpkX2FZjbOTA9SSaGbRNiaCM69EZbdDqnSIBy8CanSwO2vIKSk8eBfpFnrfUeay2g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Tue, 26 Jan 2021 17:53:11 +0800</pubDate></item><item><title>罗氏双抗 Faricimab 两项全球 III 期临床达主要终点</title><link>https://mp.weixin.qq.com/s/rN3IizUsdg4vvit_yD8zRg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYhsMIxib1xkhagpkX2FZjbO52joPJIMzExRc2KwMmw7HylXudloUicFsk2YXAIfD6gMD4iaTm6N6h3g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Tue, 26 Jan 2021 17:53:11 +0800</pubDate></item><item><title>四环医药收购北京康明百奥，布局大分子领域</title><link>https://mp.weixin.qq.com/s/zLUAK-B4_5syQV3SWZrRmA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYhsMIxib1xkhagpkX2FZjbOgjcAJCV1aahAgaZUNeMNfLRRTUuKAz6b46XEoIwAn8ttcLwxrJTH1g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Tue, 26 Jan 2021 17:53:11 +0800</pubDate></item><item><title>石药集团副总裁党群专访 | 前药技术在发现改良型新药中的应用</title><link>https://mp.weixin.qq.com/s/49CaGEwogjcZ6gsJuG2fpw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYhsMIxib1xkhagpkX2FZjbORRVrIdhFwOHQoOLIW9EnWkt7InH7icA7BGIQDDS2vX2A1u4e4bpicNTA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>IDC2021化学创新药研发与分析论坛将于2021年3月25-26日在上海盛大召开，限量免费入场券领取中]]></content:encoded><pubDate>Tue, 26 Jan 2021 17:53:11 +0800</pubDate></item><item><title>一致性评价，这 23 家药企开始了（附名单）</title><link>https://mp.weixin.qq.com/s/CA8daNXAR5oKk-D5VJQ18w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZax1qzP3pRA1r38WJbB4wiaBKUAmgKwTMbPyBWVSnAA3eePKYH82ZkhuibicRsGCZclcHQSXBiaWY3nuQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>12月一致性评价BE试验月度报告来了~]]></content:encoded><pubDate>Mon, 25 Jan 2021 17:55:47 +0800</pubDate></item><item><title>国采办：第四批国采照常进行，规则解读文件线上发布</title><link>https://mp.weixin.qq.com/s/tLDK4_oD_fI6YfQdN0OH6g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZax1qzP3pRA1r38WJbB4wiaBl2Lq8jYNdIYj8bVoom9geao4kH89bPUgLoFpanAJwEVib9ShHyPcqxg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 25 Jan 2021 17:55:47 +0800</pubDate></item><item><title>广谱抗癌！拜耳二代 TRK 抑制剂获批临床</title><link>https://mp.weixin.qq.com/s/wvPVRwwIxUhj7B-zy0dT9Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZax1qzP3pRA1r38WJbB4wiaBTWluKXeDrNNkMnBvUhnlEw1BMrLlicPI3ibjPsppWsicKL0SR3qQZBOSg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 25 Jan 2021 17:55:47 +0800</pubDate></item><item><title>Insight 数据库新功能！轻松获取项目、靶点、适应症竞争格局</title><link>https://mp.weixin.qq.com/s/SRqkpeM8hsMPko1Kbnm9Bg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZb9R9vLic84okVy0I25ar3W7aC9MnShibMIZ6MSDfDbvPxD9rm9K1JconVmv7BJkKZB2J4FQcWmGPlA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>更多新功能等你试用~]]></content:encoded><pubDate>Sat, 23 Jan 2021 12:25:44 +0800</pubDate></item><item><title>JAK1 抑制剂：艾伯维拟优先审评，恒瑞拟突破性疗法</title><link>https://mp.weixin.qq.com/s/F0Tm9Wtzr9WKRRHBVXmGkg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZb9R9vLic84okVy0I25ar3W7RxSSKjBamOzBJJcEhtKvjcCmDoO9v58LNbf0J2hjL1cmiauFHruAD7Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Sat, 23 Jan 2021 12:25:44 +0800</pubDate></item><item><title>2020 年国内「十大新药」榜单发布！PD-1、ALK、PARP……这些品种在列</title><link>https://mp.weixin.qq.com/s/J3Qoo0dqwASBkjDyO4XBFg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYDFDQgy3sXjTmNxARpEM7XiaSe3tWkJ977RDtic7bDEeUyY4uvKpsr1wwxS8IbcOWq8v7uy6Uybic7Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Fri, 22 Jan 2021 17:43:48 +0800</pubDate></item><item><title>刚刚，5 款仿制药通过一致性评价，2 款首家</title><link>https://mp.weixin.qq.com/s/hayBwE2kfRE-i1bHZvMIbQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYDFDQgy3sXjTmNxARpEM7XezY0aaOeNwMc3CwFdR0GNrYMIRDlvtlDq9tz48t2HqNwnFsVGvBlSw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Fri, 22 Jan 2021 17:43:48 +0800</pubDate></item><item><title>GSK 艾滋病新药「多替拉韦利匹韦林片」上市申请拟优先审评</title><link>https://mp.weixin.qq.com/s/9mecFy4rQbyc038o6L2-7g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYDFDQgy3sXjTmNxARpEM7Xy4ibafMnicSHicMiaJ8SfoGTFG030eDNjaaSsG0574qqR4ChTGv8EL9o6A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Fri, 22 Jan 2021 17:43:48 +0800</pubDate></item><item><title>云顶新耀 Trop-2 ADC 启动 III 期临床，乳腺癌三线治疗</title><link>https://mp.weixin.qq.com/s/DbYddBXgTn4njvRiRO70Ng</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYDFDQgy3sXjTmNxARpEM7XA7hjJxOvCZHiazQibWS5YAcFNXAibtsmuEwNJTvDJDp1CjIGca4CsUPkg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Fri, 22 Jan 2021 17:43:48 +0800</pubDate></item><item><title>信达 PD-1 新适应症上市申请拟优先审评，晚期肝癌一线治疗</title><link>https://mp.weixin.qq.com/s/vf5uYGNyuQ6sJlvRietCow</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZbvcRJHmcW9x2866HJkPw0jb1mqCQ7PYu4L9jhaoC4Z3UmXNYS5ZLaCuabqtlaiakeJ2iaZibkFZeYIg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 21 Jan 2021 16:39:51 +0800</pubDate></item><item><title>今日 5 款仿制药首家过评，3 款为首仿；3 个第四批国采品种又有企业获批</title><link>https://mp.weixin.qq.com/s/SArtREV2JHLwH811bjS6Cg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZbvcRJHmcW9x2866HJkPw0jYagBfjhGfqWnIVF4npjxXgJiaoEvWIs8jqicIuWZu0oZapU11cc6XHgQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 21 Jan 2021 16:39:51 +0800</pubDate></item><item><title>礼来「雷莫芦单抗」上市申请获受理，4 大癌种适应症已获 FDA 批准</title><link>https://mp.weixin.qq.com/s/62pGOtx1CUA3E0ZvMG2g_w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZbvcRJHmcW9x2866HJkPw0jOfGg4yGyWURpIY12P1MSbIfL7Pq1a9G3gR3M1gkEtLsYPa0h0AzLIg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 21 Jan 2021 16:39:51 +0800</pubDate></item><item><title>武田制药 ALK 抑制剂上市申请获受理，NCCN 指南推荐一线首选</title><link>https://mp.weixin.qq.com/s/Hzb4NUzUfZrxbSuvv2J14A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZbvcRJHmcW9x2866HJkPw0jZvib2BrFPGYohxZGRPaicQpa4f9MgkucnK3trjwE1TcmMBdMhyUfA6PQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 21 Jan 2021 16:39:51 +0800</pubDate></item><item><title>盘点 2020 | 药圈数字化转型元年，丁香园在做什么？</title><link>https://mp.weixin.qq.com/s/jBY11bITnLUw4BXdFOrYZQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZbvcRJHmcW9x2866HJkPw0juBY8111eZibbfTicQibyQxY53P2XrEpp8d0g4hyQibbvXkb903UnbZKplw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>你不得不了解的 2020 数字营销大事件]]></content:encoded><pubDate>Thu, 21 Jan 2021 16:39:51 +0800</pubDate></item><item><title>4 款进口新药拟突破性疗法，2 款来自武田制药</title><link>https://mp.weixin.qq.com/s/qRja9-qGa5VIApazHuqJow</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZasoBjLic4v0A9qMMUBUEzX0oIBoIIGRhbGf1t5ibJWDVrlBx331hSlmwYqsDCnFZcMAD7x94ic6BaRA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Wed, 20 Jan 2021 18:54:40 +0800</pubDate></item></channel></rss>